Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression

Claudia Mendoza-Pinto, Adriana Rojas-Villarraga, Nicolas Molano-Gonzalez, Erick A. Jimenez-Herrera, Marõa De La Luz Leon-Vazquez, Alvaro Montiel-Jarquõn, Mario Garcõa-Carrasco, Ricard Cervera

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

30 Citas (Scopus)

Resumen

Background Observational studies have indicated a high but heterogeneous prevalence of low bone mineral density (BMD) and vertebral fractures (VF) in patients with systemic lupus erythematosus (SLE). Therefore, the objectives of this systematic review and meta-regression were: 1) to compare BMD between SLE patients and healthy controls and 2) to evaluate the relationship between BMD and glucocorticoid therapy and VF in SLE patients. Methods and findings Articles were identified from electronic databases (PubMed, Embase, VHL, SciELO and the Cochrane Library). Prospective longitudinal and cross-sectional studies were considered for review. We evaluated the quality of the evidence included using the Oxford Centre for evidence- based medicine (EBM) Levels of Evidence. In total, 38 articles were identified and analyzed (3442 SLE cases and 6198 controls) in the analysis of BMD (9232 women and 408 men). There were significant differences in mean BMD between SLE patients and controls. BMD mean difference in cases/controls: -0.0566 95% CI (-0.071, -0.0439; p = > 0.0001). When only SLE patients were analyzed, the BMD did not significantly differ between patients who had or had not received glucocorticoid (GCT) therapy. 694 SLE patients were included in the analysis of VF (189 with VF vs. 505 without VF). Patients with VF had lower BMD than patients without VF (BMD mean difference without VF/with VF: 0.033 (95%CI: 0.006±0.060); p-value: 0.0156). Conclusions Patients with SLE had lower BMD than healthy controls. Moreover, SLE patients with VF had lower BMD than patients without VF. However, our data did not show that GCT therapy had an impact on BMD.

Idioma originalInglés estadounidense
Número de artículo0196113
PublicaciónPLOS ONE
Volumen13
N.º6
DOI
EstadoPublicada - jun. 2018

Áreas temáticas de ASJC Scopus

  • Bioquímica, Genética y Biología Molecular General
  • Ciencias Agrícolas y Biológicas General
  • General

Huella

Profundice en los temas de investigación de 'Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression'. En conjunto forman una huella única.

Citar esto